Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
Tito A. Sandoval(Washington University in St. Louis), Juan R. Cubillos‐Ruiz(Cornell University)
Cited by 23
Related Papers
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
|Cell|2015|921
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
|Nature|2018|408
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer
|Cancer Research|2026|2
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
|Research Square|2023|1